| . | Overall (n = 4304) . | Younger age (n = 209) . | Elderly with low comorbidity (n = 1301) . | High prevalence of atherosclerotic risks (n = 1411) . | Atherosclerotic comorbidities (n = 440) . | Prior stroke (n = 681) . | Very elderly (n = 262) . | P-value . |
|---|---|---|---|---|---|---|---|---|
| OAC | 2378 (55.3) | 54 (25.8) | 631 (48.5) | 877 (62.2) | 229 (52.1) | 460 (67.6) | 127 (48.5) | <0.001 |
| Warfarin | 1815 (42.2) | 37 (17.7) | 468 (36.0) | 636 (45.1) | 185 (42.1) | 379 (55.7) | 110 (42.0) | <0.001 |
| NOAC | 563 (13.1) | 17 (8.1) | 163 (12.5) | 241 (17.1) | 44 (10.0) | 81 (11.9) | 17 (6.5) | <0.001 |
| APD | 1180 (27.4) | 20 (9.6) | 239 (18.4) | 289 (20.5) | 335 (76.1) | 227 (33.3) | 70 (26.7) | <0.001 |
| AAD | 844 (19.6) | 68 (32.5) | 317 (24.4) | 256 (18.1) | 75 (17.1) | 95 (14.0) | 33 (12.6) | <0.001 |
| Digitalis | 487 (11.3) | 6 (2.9) | 145 (11.2) | 171 (12.1) | 44 (10.0) | 79 (11.6) | 42 (16.0) | <0.001 |
| β-Blockers | 1308 (30.4) | 68 (32.5) | 326 (25.1) | 481 (34.1) | 175 (39.8) | 164 (24.1) | 94 (35.9) | <0.001 |
| ACE-I/ARB | 1913 (44.4) | 65 (31.1) | 425 (32.7) | 736 (52.2) | 269 (61.1) | 292 (42.9) | 126 (48.1) | <0.001 |
| CCB | 1350 (31.4) | 34 (16.3) | 353 (27.1) | 532 (37.7) | 156 (35.5) | 216 (31.7) | 59 (22.5) | <0.001 |
| Statins | 1048 (24.3) | 23 (11.0) | 235 (25.0) | 243 (55.2) | 160 (23.5) | 160 (23.5) | 35 (13.4) | <0.001 |
| Loop diuretics | 975 (22.7) | 15 (7.2) | 181 (13.9) | 351 (24.9) | 149 (33.9) | 144 (21.2) | 135 (51.5) | <0.001 |
| PCI | 353 (8.2) | 5 (2.4) | 4 (0.3) | 19 (1.4) | 308 (70.0) | 9 (1.3) | 8 (3.1) | <0.001 |
| CABG | 98 (2.3) | 0 (0.0) | 4 (0.3) | 13 (0.9) | 69 (15.7) | 6 (0.9) | 6 (2.3) | <0.001 |
| Valve surgery | 184 (4.3) | 14 (6.7) | 13 (1.0) | 89 (6.3) | 13 (3.0) | 18 (2.6) | 37 (14.1) | <0.001 |
| HD | 106 (2.5) | 3 (1.4) | 0 (0.0) | 50 (3.5) | 30 (6.8) | 13 (1.9) | 10 (3.8) | <0.001 |
| Cardiac device implantation | 326 (7.6) | 7 (3.4) | 103 (7.9) | 87 (6.2) | 44 (10.0) | 40 (5.9) | 45 (17.2) | <0.001 |
| Ablation | 274 (6.4) | 37 (17.7) | 114 (8.8) | 70 (5.0) | 25 (5.7) | 23 (3.4) | 5 (1.9) | <0.001 |
| DC | 148 (3.4) | 24 (11.5) | 19 (1.5) | 60 (4.3) | 24 (5.5) | 8 (1.2) | 13 (5.0) | <0.001 |
| . | Overall (n = 4304) . | Younger age (n = 209) . | Elderly with low comorbidity (n = 1301) . | High prevalence of atherosclerotic risks (n = 1411) . | Atherosclerotic comorbidities (n = 440) . | Prior stroke (n = 681) . | Very elderly (n = 262) . | P-value . |
|---|---|---|---|---|---|---|---|---|
| OAC | 2378 (55.3) | 54 (25.8) | 631 (48.5) | 877 (62.2) | 229 (52.1) | 460 (67.6) | 127 (48.5) | <0.001 |
| Warfarin | 1815 (42.2) | 37 (17.7) | 468 (36.0) | 636 (45.1) | 185 (42.1) | 379 (55.7) | 110 (42.0) | <0.001 |
| NOAC | 563 (13.1) | 17 (8.1) | 163 (12.5) | 241 (17.1) | 44 (10.0) | 81 (11.9) | 17 (6.5) | <0.001 |
| APD | 1180 (27.4) | 20 (9.6) | 239 (18.4) | 289 (20.5) | 335 (76.1) | 227 (33.3) | 70 (26.7) | <0.001 |
| AAD | 844 (19.6) | 68 (32.5) | 317 (24.4) | 256 (18.1) | 75 (17.1) | 95 (14.0) | 33 (12.6) | <0.001 |
| Digitalis | 487 (11.3) | 6 (2.9) | 145 (11.2) | 171 (12.1) | 44 (10.0) | 79 (11.6) | 42 (16.0) | <0.001 |
| β-Blockers | 1308 (30.4) | 68 (32.5) | 326 (25.1) | 481 (34.1) | 175 (39.8) | 164 (24.1) | 94 (35.9) | <0.001 |
| ACE-I/ARB | 1913 (44.4) | 65 (31.1) | 425 (32.7) | 736 (52.2) | 269 (61.1) | 292 (42.9) | 126 (48.1) | <0.001 |
| CCB | 1350 (31.4) | 34 (16.3) | 353 (27.1) | 532 (37.7) | 156 (35.5) | 216 (31.7) | 59 (22.5) | <0.001 |
| Statins | 1048 (24.3) | 23 (11.0) | 235 (25.0) | 243 (55.2) | 160 (23.5) | 160 (23.5) | 35 (13.4) | <0.001 |
| Loop diuretics | 975 (22.7) | 15 (7.2) | 181 (13.9) | 351 (24.9) | 149 (33.9) | 144 (21.2) | 135 (51.5) | <0.001 |
| PCI | 353 (8.2) | 5 (2.4) | 4 (0.3) | 19 (1.4) | 308 (70.0) | 9 (1.3) | 8 (3.1) | <0.001 |
| CABG | 98 (2.3) | 0 (0.0) | 4 (0.3) | 13 (0.9) | 69 (15.7) | 6 (0.9) | 6 (2.3) | <0.001 |
| Valve surgery | 184 (4.3) | 14 (6.7) | 13 (1.0) | 89 (6.3) | 13 (3.0) | 18 (2.6) | 37 (14.1) | <0.001 |
| HD | 106 (2.5) | 3 (1.4) | 0 (0.0) | 50 (3.5) | 30 (6.8) | 13 (1.9) | 10 (3.8) | <0.001 |
| Cardiac device implantation | 326 (7.6) | 7 (3.4) | 103 (7.9) | 87 (6.2) | 44 (10.0) | 40 (5.9) | 45 (17.2) | <0.001 |
| Ablation | 274 (6.4) | 37 (17.7) | 114 (8.8) | 70 (5.0) | 25 (5.7) | 23 (3.4) | 5 (1.9) | <0.001 |
| DC | 148 (3.4) | 24 (11.5) | 19 (1.5) | 60 (4.3) | 24 (5.5) | 8 (1.2) | 13 (5.0) | <0.001 |
Categorical variables are presented as numbers (%).
AAD, antiarrhythmic drugs; ACE-I, angiotensin-converting enzyme inhibitor; APD, antiplatelet drug; ARB, angiotensin II receptor blocker; CABG, coronary artery bypass graft; CCB, calcium channel blocker; DC, direct current conversion; HD, haemodialysis; NOAC, non-vitamin K oral anticoagulants; OAC, oral anticoagulants; PCI, percutaneous coronary intervention.
| . | Overall (n = 4304) . | Younger age (n = 209) . | Elderly with low comorbidity (n = 1301) . | High prevalence of atherosclerotic risks (n = 1411) . | Atherosclerotic comorbidities (n = 440) . | Prior stroke (n = 681) . | Very elderly (n = 262) . | P-value . |
|---|---|---|---|---|---|---|---|---|
| OAC | 2378 (55.3) | 54 (25.8) | 631 (48.5) | 877 (62.2) | 229 (52.1) | 460 (67.6) | 127 (48.5) | <0.001 |
| Warfarin | 1815 (42.2) | 37 (17.7) | 468 (36.0) | 636 (45.1) | 185 (42.1) | 379 (55.7) | 110 (42.0) | <0.001 |
| NOAC | 563 (13.1) | 17 (8.1) | 163 (12.5) | 241 (17.1) | 44 (10.0) | 81 (11.9) | 17 (6.5) | <0.001 |
| APD | 1180 (27.4) | 20 (9.6) | 239 (18.4) | 289 (20.5) | 335 (76.1) | 227 (33.3) | 70 (26.7) | <0.001 |
| AAD | 844 (19.6) | 68 (32.5) | 317 (24.4) | 256 (18.1) | 75 (17.1) | 95 (14.0) | 33 (12.6) | <0.001 |
| Digitalis | 487 (11.3) | 6 (2.9) | 145 (11.2) | 171 (12.1) | 44 (10.0) | 79 (11.6) | 42 (16.0) | <0.001 |
| β-Blockers | 1308 (30.4) | 68 (32.5) | 326 (25.1) | 481 (34.1) | 175 (39.8) | 164 (24.1) | 94 (35.9) | <0.001 |
| ACE-I/ARB | 1913 (44.4) | 65 (31.1) | 425 (32.7) | 736 (52.2) | 269 (61.1) | 292 (42.9) | 126 (48.1) | <0.001 |
| CCB | 1350 (31.4) | 34 (16.3) | 353 (27.1) | 532 (37.7) | 156 (35.5) | 216 (31.7) | 59 (22.5) | <0.001 |
| Statins | 1048 (24.3) | 23 (11.0) | 235 (25.0) | 243 (55.2) | 160 (23.5) | 160 (23.5) | 35 (13.4) | <0.001 |
| Loop diuretics | 975 (22.7) | 15 (7.2) | 181 (13.9) | 351 (24.9) | 149 (33.9) | 144 (21.2) | 135 (51.5) | <0.001 |
| PCI | 353 (8.2) | 5 (2.4) | 4 (0.3) | 19 (1.4) | 308 (70.0) | 9 (1.3) | 8 (3.1) | <0.001 |
| CABG | 98 (2.3) | 0 (0.0) | 4 (0.3) | 13 (0.9) | 69 (15.7) | 6 (0.9) | 6 (2.3) | <0.001 |
| Valve surgery | 184 (4.3) | 14 (6.7) | 13 (1.0) | 89 (6.3) | 13 (3.0) | 18 (2.6) | 37 (14.1) | <0.001 |
| HD | 106 (2.5) | 3 (1.4) | 0 (0.0) | 50 (3.5) | 30 (6.8) | 13 (1.9) | 10 (3.8) | <0.001 |
| Cardiac device implantation | 326 (7.6) | 7 (3.4) | 103 (7.9) | 87 (6.2) | 44 (10.0) | 40 (5.9) | 45 (17.2) | <0.001 |
| Ablation | 274 (6.4) | 37 (17.7) | 114 (8.8) | 70 (5.0) | 25 (5.7) | 23 (3.4) | 5 (1.9) | <0.001 |
| DC | 148 (3.4) | 24 (11.5) | 19 (1.5) | 60 (4.3) | 24 (5.5) | 8 (1.2) | 13 (5.0) | <0.001 |
| . | Overall (n = 4304) . | Younger age (n = 209) . | Elderly with low comorbidity (n = 1301) . | High prevalence of atherosclerotic risks (n = 1411) . | Atherosclerotic comorbidities (n = 440) . | Prior stroke (n = 681) . | Very elderly (n = 262) . | P-value . |
|---|---|---|---|---|---|---|---|---|
| OAC | 2378 (55.3) | 54 (25.8) | 631 (48.5) | 877 (62.2) | 229 (52.1) | 460 (67.6) | 127 (48.5) | <0.001 |
| Warfarin | 1815 (42.2) | 37 (17.7) | 468 (36.0) | 636 (45.1) | 185 (42.1) | 379 (55.7) | 110 (42.0) | <0.001 |
| NOAC | 563 (13.1) | 17 (8.1) | 163 (12.5) | 241 (17.1) | 44 (10.0) | 81 (11.9) | 17 (6.5) | <0.001 |
| APD | 1180 (27.4) | 20 (9.6) | 239 (18.4) | 289 (20.5) | 335 (76.1) | 227 (33.3) | 70 (26.7) | <0.001 |
| AAD | 844 (19.6) | 68 (32.5) | 317 (24.4) | 256 (18.1) | 75 (17.1) | 95 (14.0) | 33 (12.6) | <0.001 |
| Digitalis | 487 (11.3) | 6 (2.9) | 145 (11.2) | 171 (12.1) | 44 (10.0) | 79 (11.6) | 42 (16.0) | <0.001 |
| β-Blockers | 1308 (30.4) | 68 (32.5) | 326 (25.1) | 481 (34.1) | 175 (39.8) | 164 (24.1) | 94 (35.9) | <0.001 |
| ACE-I/ARB | 1913 (44.4) | 65 (31.1) | 425 (32.7) | 736 (52.2) | 269 (61.1) | 292 (42.9) | 126 (48.1) | <0.001 |
| CCB | 1350 (31.4) | 34 (16.3) | 353 (27.1) | 532 (37.7) | 156 (35.5) | 216 (31.7) | 59 (22.5) | <0.001 |
| Statins | 1048 (24.3) | 23 (11.0) | 235 (25.0) | 243 (55.2) | 160 (23.5) | 160 (23.5) | 35 (13.4) | <0.001 |
| Loop diuretics | 975 (22.7) | 15 (7.2) | 181 (13.9) | 351 (24.9) | 149 (33.9) | 144 (21.2) | 135 (51.5) | <0.001 |
| PCI | 353 (8.2) | 5 (2.4) | 4 (0.3) | 19 (1.4) | 308 (70.0) | 9 (1.3) | 8 (3.1) | <0.001 |
| CABG | 98 (2.3) | 0 (0.0) | 4 (0.3) | 13 (0.9) | 69 (15.7) | 6 (0.9) | 6 (2.3) | <0.001 |
| Valve surgery | 184 (4.3) | 14 (6.7) | 13 (1.0) | 89 (6.3) | 13 (3.0) | 18 (2.6) | 37 (14.1) | <0.001 |
| HD | 106 (2.5) | 3 (1.4) | 0 (0.0) | 50 (3.5) | 30 (6.8) | 13 (1.9) | 10 (3.8) | <0.001 |
| Cardiac device implantation | 326 (7.6) | 7 (3.4) | 103 (7.9) | 87 (6.2) | 44 (10.0) | 40 (5.9) | 45 (17.2) | <0.001 |
| Ablation | 274 (6.4) | 37 (17.7) | 114 (8.8) | 70 (5.0) | 25 (5.7) | 23 (3.4) | 5 (1.9) | <0.001 |
| DC | 148 (3.4) | 24 (11.5) | 19 (1.5) | 60 (4.3) | 24 (5.5) | 8 (1.2) | 13 (5.0) | <0.001 |
Categorical variables are presented as numbers (%).
AAD, antiarrhythmic drugs; ACE-I, angiotensin-converting enzyme inhibitor; APD, antiplatelet drug; ARB, angiotensin II receptor blocker; CABG, coronary artery bypass graft; CCB, calcium channel blocker; DC, direct current conversion; HD, haemodialysis; NOAC, non-vitamin K oral anticoagulants; OAC, oral anticoagulants; PCI, percutaneous coronary intervention.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
